-
EZ Cap Cy5 Firefly Luciferase mRNA Guide
2026-08-20
EZ Cap Cy5 Firefly Luciferase mRNA links direct Cy5-based transport measurements with Firefly luciferase expression analysis. This guide explains how to interpret the two signals, design defensible mRNA delivery and transfection experiments, and apply evidence from a recent lipoplex study.
-
Antipyrine in BBB Permeability Workflows
2026-08-19
Antipyrine offers a highly soluble, high-purity research compound for building reproducible permeability, transport, and pharmacokinetic workflows. Used alongside LLC-PK1-MOCK/MDR1 assays, it helps separate practical assay variability from transporter effects and lysosomal trapping while supporting pain, fever, and CNS research applications.
-
BMS 309403 Workflow for FABP4 Research
2026-08-19
Build reproducible macrophage, foam-cell, vascular, and metabolic assays around BMS 309403, a potent and selective FABP4 inhibitor. This guide connects compound handling and dose design with the SERCA2–calcineurin–FoxO1–FABP4 mechanism implicated in atherosclerosis and inflammation.
-
High-Throughput Surrogate Models for BBB Permeability
2026-08-18
Hu and colleagues developed a Transwell blood-brain barrier surrogate using LLC-PK1-MOCK/MDR1 cells and combined permeability, P-glycoprotein efflux, and recovery measurements with lysosomal-trapping correction. Across 41 compounds, the approach correlated in vitro transport with unbound brain distribution and offered a practical framework for earlier CNS candidate prioritization.
-
Proteome Preservation in Bone Regeneration Research
2026-08-18
A translational perspective on how MS-compatible protease control can preserve mechanistic evidence in irradiated BMSC and migrasome research, with practical guidance for using APExBIO Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO).
-
GDC-0068 (RG7440) for Spatial mTORC1 Assays
2026-08-17
GDC-0068 (RG7440) provides a selective pan-AKT perturbation strategy for linking PI3K/Akt signaling to cell fate, genotype-dependent drug response, and mTORC1 output. Used alongside compartment-targeted tools, it helps distinguish upstream pathway dependence from the spatial functions of nuclear and lysosomal mTORC1.
-
α-Bungarotoxin for Nicotinic Receptor Blockade
2026-08-17
Use α-Bungarotoxin to convert α7 nAChR activation from an assumption into a testable experimental variable across neuronal, neuromuscular, and placental models. This guide combines receptor-blockade workflows, pathway-level controls, assay optimization, and troubleshooting for cholinergic signaling studies.
-
3X FLAG Peptide for Translational Mechanism
2026-08-16
Mechanistic studies of CDK4, 4E-BP1, and mTOR inhibitor resistance require more than a phosphorylation signal: they require confident protein recovery, identity confirmation, and functional follow-through. This thought-leadership guide explains how the 3X (DYKDDDDK) Peptide can strengthen FLAG-based assay architecture while preserving a disciplined connection between chemoproteomic discovery and translational validation.
-
Chlorin e6: PDT Workflows and Optimization
2026-08-15
Chlorin e6 supports controllable ROS-based experiments spanning cancer-cell photodynamic therapy and antibacterial wound-material research. This workflow-focused guide connects free Ce6 dosing, light calibration, apoptosis assays, and Ce6-functionalized silk fibroin scaffolds while emphasizing controls and troubleshooting.
-
Tricine-SDS-PAGE Gel Preparation Kit Guide
2026-08-14
The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit is intended for resolving low-molecular-weight proteins and peptides that may be poorly separated by conventional Tris-SDS-PAGE. It supports research workflows including denaturing and non-denaturing electrophoresis, but it is not intended for diagnostic, clinical, or medical use.
-
Sodium Nitroprusside in Vascular Assays
2026-08-14
Use Sodium Nitroprusside as a controlled nitric oxide donor challenge to separate vascular smooth muscle responsiveness from upstream hypertension mechanisms. This practical guide connects sex-stratified angiotensin II research with tissue, platelet, and integrated assay workflows, including preparation parameters and troubleshooting strategies.
-
Tamoxifen and PINK1: Designing Better Cancer Assays
2026-08-13
Tamoxifen is more than a selective estrogen receptor modulator: in conditional genetics, it can shape the biological readouts researchers measure. This article explains how to use Tamoxifen CreER-mediated gene knockout models to interrogate PINK1, mitochondrial iron, autophagy, and tumorigenesis without confusing induction effects with disease biology.
-
FAK Inhibitor 14: Applied Research Workflows
2026-08-13
FAK Inhibitor 14 enables pharmacological interrogation of FAK/Src signaling in migration, EMT, and cholesterol-adapted ovarian cancer models. This guide combines practical dosing, pathway-level readouts, comparative assay design, and troubleshooting for reproducible cancer biology research.
-
Radicicol Workflows for Hsp90 and Metabolic Research
2026-08-12
Radicicol is a versatile Hsp90 inhibitor for connecting protein-quality control with adipogenesis, apoptosis, inflammation, and antigen cross-presentation assays. This guide converts its pharmacology into practical dose-finding, control design, nanoparticle studies, and troubleshooting workflows.
-
Z-LEHD-FMK: From Apoptosis to Translation
2026-08-12
A thought-leadership guide to using Z-LEHD-FMK as an irreversible caspase-9 inhibitor for causal pathway dissection, time-resolved apoptosis assays, cancer research, and neuroprotection in spinal cord injury. The article connects mitochondrial apoptosis biology with translational study design, emphasizing orthogonal readouts, model-specific controls, and the limits of extrapolating cytoprotection into therapeutic claims.